341 related articles for article (PubMed ID: 21543928)
21. Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer.
Chen Y; Zhang L; Lv R; Zhang WQ
Asian Pac J Cancer Prev; 2013; 14(10):5883-90. PubMed ID: 24289594
[TBL] [Abstract][Full Text] [Related]
22. FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production.
Versteeg HH; Spek CA; Slofstra SH; Diks SH; Richel DJ; Peppelenbosch MP
Circ Res; 2004 Apr; 94(8):1032-40. PubMed ID: 15016732
[TBL] [Abstract][Full Text] [Related]
23. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S
Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499
[TBL] [Abstract][Full Text] [Related]
24. Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor.
Åberg M; Eriksson O; Mokhtari D; Siegbahn A
Thromb Haemost; 2014 Apr; 111(4):748-60. PubMed ID: 24336871
[TBL] [Abstract][Full Text] [Related]
25. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
[TBL] [Abstract][Full Text] [Related]
26. Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer.
Xie X; Yang M; Ding Y; Yu L; Chen J
Oncol Rep; 2017 Dec; 38(6):3297-3308. PubMed ID: 29039544
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA‑320 targets mitogen‑activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer.
Xu Y; Hu J; Zhang C; Liu Y
Mol Med Rep; 2017 Dec; 16(6):8530-8536. PubMed ID: 28990044
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer.
Cao Y; Shi H; Ren F; Jia Y; Zhang R
Exp Cell Res; 2017 Oct; 359(1):185-194. PubMed ID: 28754469
[TBL] [Abstract][Full Text] [Related]
29. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor.
Poulsen LK; Jacobsen N; Sørensen BB; Bergenhem NC; Kelly JD; Foster DC; Thastrup O; Ezban M; Petersen LC
J Biol Chem; 1998 Mar; 273(11):6228-32. PubMed ID: 9497347
[TBL] [Abstract][Full Text] [Related]
30. Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells.
Demetz G; Seitz I; Stein A; Steppich B; Groha P; Brandl R; Schömig A; Ott I
Atherosclerosis; 2010 Oct; 212(2):466-71. PubMed ID: 20708733
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA‑139 suppressed tumor cell proliferation, migration and invasion by directly targeting HDGF in epithelial ovarian cancer.
Liu J; Jin S; Wang R
Mol Med Rep; 2017 Sep; 16(3):3379-3386. PubMed ID: 28713954
[TBL] [Abstract][Full Text] [Related]
32. TF/FVIIa transactivate PDGFRbeta to regulate PDGF-BB-induced chemotaxis in different cell types: involvement of Src and PLC.
Siegbahn A; Johnell M; Nordin A; Aberg M; Velling T
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):135-41. PubMed ID: 17991872
[TBL] [Abstract][Full Text] [Related]
33. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
Aberg M; Johnell M; Wickström M; Siegbahn A
Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
[TBL] [Abstract][Full Text] [Related]
34. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
[TBL] [Abstract][Full Text] [Related]
35. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
[TBL] [Abstract][Full Text] [Related]
36. SNAIL gene inhibited by hypoxia-inducible factor 1α (HIF-1α) in epithelial ovarian cancer.
Zhang P; Liu Y; Feng Y; Gao S
Int J Immunopathol Pharmacol; 2016 Sep; 29(3):364-75. PubMed ID: 27044634
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
[TBL] [Abstract][Full Text] [Related]
38. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
Zhang Y; Xu Y; Ma J; Pang X; Dong M
Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613
[TBL] [Abstract][Full Text] [Related]
39. Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.
Guo D; Zhou H; Wu Y; Zhou F; Xu G; Wen H; Zhang X
Tumour Biol; 2011 Oct; 32(5):921-30. PubMed ID: 21625939
[TBL] [Abstract][Full Text] [Related]
40. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.
Kim S; Gwak H; Kim HS; Kim B; Dhanasekaran DN; Song YS
Oncotarget; 2016 Dec; 7(50):83148-83159. PubMed ID: 27825119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]